 |
T cell receptor (TCR) peptide (BV5S2, BV6S5, BV13S1) vaccine |
|---|---|
| Trade Name | Neurovax |
| Orphan Indication | Pediatric multiple sclerosis |
| USA Market Approval | USA |
| USA Designation Date | 2014-02-06 00:00:00 |
| Sponsor | Immune Response BioPharma, Inc.;244 5th Avenue, Suite 1727;New York, 10001 |
